Drug-Coated Balloon Angioplasty for Carotid Artery Occlusion Caused by Takayasu Arteritis

Keqiang Zhao1, Rongrong Zhu1, Weiwei Wu1

  • 1Department of Vascular surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Insights

Takayasu arteritis (TA) can cause supra-aortic artery occlusion. Drug-coated balloon angioplasty successfully treated a patient with right common carotid artery stenosis, offering a potential new treatment for TA vascular lesions.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Takayasu arteritis (TA) is a chronic inflammatory condition affecting large arteries, primarily the aorta and its branches.
  • Supra-aortic artery involvement in TA can lead to severe stenosis or occlusion, causing diverse neurological and vascular symptoms.
  • Current treatment strategies for TA include immunosuppression and revascularization, with varying success rates.

Observation:

  • A 27-year-old male presented with dizziness and amaurosis, diagnosed with Takayasu arteritis.
  • Computed tomography angiography revealed occlusion of all supra-aortic arteries, except for an aberrant right subclavian artery.
  • The patient had significant stenosis in the right common carotid artery.

Findings:

  • The patient underwent successful drug-coated balloon (DCB) angioplasty for the right common carotid artery lesion.
  • Post-procedure, the patient experienced symptom resolution and maintained patency of the treated artery at six-month follow-up.
  • No recurrence of symptoms or restenosis was observed on follow-up imaging.

Implications:

  • Drug-coated balloon angioplasty demonstrates promising efficacy in treating supra-aortic artery lesions in Takayasu arteritis.
  • DCB angioplasty may represent a novel, minimally invasive therapeutic option for selected TA patients with vascular stenosis.
  • This case highlights the potential for DCB technology in managing complex arterial inflammatory diseases.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
161
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
160
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
250
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
163
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
348
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
153